Quick Answer
Medpace Holdings, Inc. reported Total Revenue of $2.53 billion for fiscal year 2025.
Medpace Holdings, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $2.53B +20.0% |
$2.11B +11.8% |
$1.89B +29.2% |
$1.46B +27.8% |
$1.14B +23.4% |
$925.92M +7.5% |
| Revenue (ASC 606) | $2.53B +20.0% |
$2.11B +11.8% |
$1.89B +29.2% |
$1.46B +27.8% |
$1.14B +23.4% |
$925.92M +7.5% |
| Net Income | $451.12M +11.6% |
$404.39M +43.0% |
$282.81M +15.3% |
$245.37M +34.9% |
$181.85M +25.1% |
$145.38M +44.7% |
| Diluted EPS | $15.28 +21.0% |
$12.63 +42.2% |
$8.88 +22.0% |
$7.28 +51.4% |
$4.81 +25.3% |
$3.84 +43.8% |
| Total Assets | $1.98B -6.0% |
$2.10B +26.8% |
$1.66B +22.5% |
$1.35B -18.5% |
$1.66B +19.4% |
$1.39B +21.7% |
| Cash and Equivalents | $497.05M -25.8% |
$669.44M +172.7% |
$245.45M +768.4% |
$28.27M -93.9% |
$461.30M +66.1% |
$277.77M +110.6% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | $459.07M -44.4% |
$825.54M +47.7% |
$558.95M +44.7% |
$386.39M -59.5% |
$952.93M +18.3% |
$805.78M +10.9% |
| Operating Income | $534.93M +19.7% |
$446.87M +32.7% |
$336.82M +20.9% |
$278.70M +40.3% |
$198.62M +18.9% |
$167.04M +31.3% |
| Shares Outstanding | 28.37M -7.4% |
30.63M -0.4% |
30.75M -1.1% |
31.09M -13.7% |
36.01M +1.4% |
35.52M -1.5% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $659.90M | +23.7% | +9.4% |
| Revenue (ASC 606) | September 30, 2025 | $659.90M | +23.7% | +9.4% |
| Net Income | September 30, 2025 | $111.14M | +15.3% | +23.1% |
| Diluted EPS | September 30, 2025 | $3.86 | +28.2% | +24.5% |
| Total Assets | September 30, 2025 | $1.75B | -15.9% | +11.5% |
| Cash and Equivalents | September 30, 2025 | $285.35M | -56.6% | +515.9% |
| Long-Term Debt | September 30, 2019 | $0.00 | -100.0% | — |
| Stockholders Equity | September 30, 2025 | $293.64M | -66.7% | +70.4% |
| Operating Income | September 30, 2025 | $141.81M | +26.3% | +12.2% |
| Shares Outstanding | September 30, 2025 | 28.17M | -9.4% | +0.3% |
- Medpace Holdings, Inc. reported Total Revenue of $2.53 billion for fiscal year 2025.
- Medpace Holdings, Inc. showed an increase of +20.0% in Total Revenue compared to the prior fiscal year.
- Medpace Holdings, Inc. reported Revenue (ASC 606) of $2.53 billion for fiscal year 2025.
- Medpace Holdings, Inc. showed an increase of +20.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Medpace Holdings, Inc. reported Net Income of $451.12 million for fiscal year 2025.
- Medpace Holdings, Inc. showed an increase of +11.6% in Net Income compared to the prior fiscal year.
- Medpace Holdings, Inc. reported Diluted EPS of $15.28 per share for fiscal year 2025.
- Medpace Holdings, Inc. showed an increase of +21.0% in Diluted EPS compared to the prior fiscal year.
- Medpace Holdings, Inc. reported Total Assets of $1.98 billion for fiscal year 2025.
- Medpace Holdings, Inc. showed a decrease of -6.0% in Total Assets compared to the prior fiscal year.
- Medpace Holdings, Inc. reported Cash and Equivalents of $497.05 million for fiscal year 2025.
- Medpace Holdings, Inc. showed a decrease of -25.8% in Cash and Equivalents compared to the prior fiscal year.
- Medpace Holdings, Inc. reported Long-Term Debt of $0.00 for fiscal year 2019.
- Medpace Holdings, Inc. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- Medpace Holdings, Inc. reported Stockholders Equity of $459.07 million for fiscal year 2025.
- Medpace Holdings, Inc. showed a decrease of -44.4% in Stockholders Equity compared to the prior fiscal year.
- Medpace Holdings, Inc. reported Operating Income of $534.93 million for fiscal year 2025.
- Medpace Holdings, Inc. showed an increase of +19.7% in Operating Income compared to the prior fiscal year.
- Medpace Holdings, Inc. reported Shares Outstanding of 28.37 million shares for fiscal year 2025.
- Medpace Holdings, Inc. showed a decrease of -7.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: